Literature DB >> 33998849

An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom.

Jonathan Paul Liebling1,2, Nicholas James Clarkson3, Blair William Gibbs1, Andrew Stephen Yates1, Saoirse Elizabeth O'Sullivan1,4.   

Abstract

Introduction: Over-the-counter cannabidiol (CBD) products have seen unprecedented recent growth in the United Kingdom. However, analysis of these predominantly unregulated products from other countries tells us that they are often mislabeled or contain unlabeled and potentially dangerous chemicals. Thus, the aim of the present study was to analyze CBD oils available in the United Kingdom. Materials and
Methods: Phytocannabinoids, residual solvent, and heavy metals were measured blinded in 29 widely available CBD products by an independent testing facility using high-performance liquid chromatography with diode-array detection for cannabinoids, Headspace-gas chromatography-flame ionization detector and gas chromatography-mass spectrometry for residual solvents, and inductively coupled plasma-mass spectrometry for heavy metals.
Results: The mean advertised CBD content was 4.5%, and the actual mean measured CBD content of products was 3.2% (p=0.053, Mann-Whitney test). Only 11/29 (38%) products were within 10% of the advertised CBD content. Fifty five percent of products had measurable levels of the controlled substances Δ9-tetrahydrocannabinol (mean content 0.04%) or cannabinol (mean content 0.01%), as well as most other phytocannabinoid compounds including cannabidiolic acid (CBDA), cannabidivarin (CBDV), and cannabidivarin acid (CBDVA). Detectable levels of N-pentane, ethanol, isopropanol, heptane, lead, and arsenic were found in many of the CBD products, but these were within acceptable levels. Conclusions: As demonstrated in other countries, the quality of over-the-counter CBD products in the United Kingdom can be substandard, particularly with regard to CBD content, and often contains levels of controlled substances. We recommend that these products be more strictly regulated for consumer welfare.

Entities:  

Keywords:  cannabidiol; over the counter; phytocannabinoid; quality

Mesh:

Substances:

Year:  2020        PMID: 33998849      PMCID: PMC9070743          DOI: 10.1089/can.2019.0078

Source DB:  PubMed          Journal:  Cannabis Cannabinoid Res        ISSN: 2378-8763


  22 in total

1.  Effect of combined oral doses of Δ(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models.

Authors:  Erin M Rock; Cassidy Connolly; Cheryl L Limebeer; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2016-07-20       Impact factor: 4.530

Review 2.  Cannabidiol Adverse Effects and Toxicity.

Authors:  Marilyn A Huestis; Renata Solimini; Simona Pichini; Roberta Pacifici; Jeremy Carlier; Francesco Paolo Busardò
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

Review 3.  The Role of Nuclear Hormone Receptors in Cannabinoid Function.

Authors:  Marco Pistis; Saoirse E O'Sullivan
Journal:  Adv Pharmacol       Date:  2017-05-25

4.  Labeling Accuracy of Cannabidiol Extracts Sold Online.

Authors:  Marcel O Bonn-Miller; Mallory J E Loflin; Brian F Thomas; Jahan P Marcu; Travis Hyke; Ryan Vandrey
Journal:  JAMA       Date:  2017-11-07       Impact factor: 56.272

5.  The unexpected identification of the cannabimimetic, 5F-ADB, and dextromethorphan in commercially available cannabidiol e-liquids.

Authors:  Justin L Poklis; Haley A Mulder; Michelle R Peace
Journal:  Forensic Sci Int       Date:  2018-11-01       Impact factor: 2.395

6.  Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis.

Authors:  Carmen Rodríguez-Cueto; Irene Santos-García; Laura García-Toscano; Francisco Espejo-Porras; MLuz Bellido; Javier Fernández-Ruiz; Eduardo Muñoz; Eva de Lago
Journal:  Biochem Pharmacol       Date:  2018-08-01       Impact factor: 5.858

Review 7.  Molecular Targets of Cannabidiol in Neurological Disorders.

Authors:  Clementino Ibeas Bih; Tong Chen; Alistair V W Nunn; Michaël Bazelot; Mark Dallas; Benjamin J Whalley
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

8.  A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans.

Authors:  Sophie A Millar; Nicole L Stone; Andrew S Yates; Saoirse E O'Sullivan
Journal:  Front Pharmacol       Date:  2018-11-26       Impact factor: 5.810

9.  A systematic review of cannabidiol dosing in clinical populations.

Authors:  S A Millar; N L Stone; Z D Bellman; A S Yates; T J England; S E O'Sullivan
Journal:  Br J Clin Pharmacol       Date:  2019-07-19       Impact factor: 4.335

10.  A Cross-Sectional Study of Cannabidiol Users.

Authors:  Jamie Corroon; Joy A Phillips
Journal:  Cannabis Cannabinoid Res       Date:  2018-07-01
View more
  7 in total

1.  Cannabidiol Μay Prolong Survival in Patients With Glioblastoma Multiforme.

Authors:  Rudolf Likar; Markus Koestenberger; Martin Stutschnig; Gerhard Nahler
Journal:  Cancer Diagn Progn       Date:  2021-05-03

2.  A survey of cannabinoids and toxic elements in hemp-derived products from the United States marketplace.

Authors:  Geoffrey A Dubrow; Rahul S Pawar; Cynthia Srigley; Jennifer Fong Sam; Christian Talavera; Christine H Parker; Gregory O Noonan
Journal:  J Food Compost Anal       Date:  2021-04-01       Impact factor: 4.520

3.  Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim.

Authors:  Erin Johnson; Michael Kilgore; Shanna Babalonis
Journal:  J Cannabis Res       Date:  2022-06-06

4.  Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients.

Authors:  MaryBeth Dobbins; Mannat Rakkar; Katharine Cunnane; Sarah D Pennypacker; Kimberly G Wagoner; Beth A Reboussin; E Alfonso Romero-Sandoval
Journal:  Front Public Health       Date:  2022-06-17

5.  Semiquantitative Screening of THC Analogues by Silica Gel TLC with an Ag(I) Retention Zone and Chromogenic Smartphone Detection.

Authors:  Si Huang; Ruiying Qiu; Zhengfa Fang; Ke Min; Teris A van Beek; Ming Ma; Bo Chen; Han Zuilhof; Gert Ij Salentijn
Journal:  Anal Chem       Date:  2022-09-30       Impact factor: 8.008

Review 6.  Palmitoylethanolamide: A Natural Compound for Health Management.

Authors:  Paul Clayton; Mariko Hill; Nathasha Bogoda; Silma Subah; Ruchitha Venkatesh
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

Review 7.  Cannabidiol (CBD) Use by Older Adults for Acute and Chronic Pain.

Authors:  Brooke Porter; Barbara St Marie; Gary Milavetz; Keela Herr
Journal:  J Gerontol Nurs       Date:  2021-07-01       Impact factor: 1.436

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.